Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A8216 PP 2 (AG 1879)2 CitationSummary: Src-family kinases inhibitor -
A8245 Sorafenib Tosylate1 CitationTarget: Raf|VEGFRSummary: Raf kinases and tyrosine kinases inhibitor -
A8247 Afatinib (BIBW2992)1 CitationTarget: EGFRSummary: Irreversible EGFR/HER2 inhibitor -
A8251 TAE684 (NVP-TAE684)Summary: ALK inhibitor,potent and selective -
A8252 Nintedanib (BIBF 1120)3 CitationTarget: VEGFR|PDGFR|FGFRSummary: VEGFR/PDGFR/FGFR inhibitor -
A8255 Sunitinib malate5 CitationTarget: VEGFRSummary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor -
A2149 Bosutinib (SKI-606)1 CitationTarget: Bcr-Abl|SrcSummary: Potent Abl/Src kinases -
A2307 PHA-6657521 CitationTarget: c-METSummary: C-Met inhibitor,potent and ATP-competitive -
A1821 Ki8751Target: VEGFRSummary: VEGFR-2 inhibitor,potent and selective -
A2678 SU112742 CitationTarget: METSummary: C-Met inhibitor,potent and selective

